Web11 apr. 2024 · DermTech, Inc. heeft een overeenkomst aangekondigd met een Blues Plan in North Carolina. Het contract, dat een aanvulling is op een gunstig dekkingsbeleid dat op 15 maart 2024 van kracht werd,... 13 april 2024 Web26 aug. 2024 · The estimated net worth of Matthew S. Mcilwain is at least $923,100.75 as of August 26th, 2024. Mr. Mcilwain owns 335,673 shares of Nautilus Biotechnology stock worth more than $923,101 as of April 4th. This net worth estimate does not reflect any other assets that Mr. Mcilwain may own.
Posard - Address, Phone Number, Public Records - page 1
Web10 sep. 2024 · Visualizing Gene Expression in Situ Leaders in spatially resolved, single-cell transcriptomics Web17 nov. 2024 · A seasoned executive in the genomics and life science space, Matt has an extensive background in launching novel and transformational products, generating high revenue growth, and effectively scaling organizations. company achievements presentation
Company - Nautilus Biotechnology
Web1 feb. 2006 · SAN DIEGO--(BUSINESS WIRE)--Feb. 1, 2006--Illumina, Inc. (NASDAQ:ILMN) announced today the appointment of Matthew L. Posard as VicePresident of Marketing. Mr. Posard will be responsible for … WebMatthew L. Posard is a businessperson who has been at the head of 7 different companies and currently is Chairman at DermTech, Inc., Executive Chairman of Stemson … WebMatt Posard Chief Strategist Advisory Board Euan Ashley, MD PhD Scientific Co-Founder Timothy McDaniel, PhD Scientific Advisor Christina Curtis, PhD Scientific Advisor … eat to evolve ゲーム